Manufacturer of Controlled Substances Registration: S & B PHARMA, INC.; Correction

---
identifier: "/us/fr/2015-13832"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances Registration: S & B PHARMA, INC.; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2015-13832"
section_name: "Manufacturer of Controlled Substances Registration: S & B PHARMA, INC.; Correction"
positive_law: false
currency: "2015-06-08"
last_updated: "2015-06-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2015-13832"
document_type: "notice"
publication_date: "2015-06-08"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "80 FR 32412"
fr_volume: 80
docket_ids:
  - "Docket No. DEA-392"
fr_action: "Notice of registration; correction."
---


#  Manufacturer of Controlled Substances Registration: S & B PHARMA, INC.; Correction

**ACTION:**

Notice of registration; correction.

**SUMMARY:**

The Drug Enforcement Administration (DEA) published a document in the *Federal Register* of January 26, 2015, concerning a notice of registration that inadvertently stated no comments or objections were submitted in the notice.

**Correction**

In the *Federal Register* of January 26, 2015, FR Doc. 2015-01287 (80 FR 3988), page 3988, make the following correction. In the second column, the first paragraph of the *SUPPLEMENTARY INFORMATION* caption, remove the last sentence and add in its place the following:

One comment of objection was received on this registration on August 28, 2014. However, after a thorough review of this matter, the Drug Enforcement Administration has concluded that the issues raised in the comment and objection do not warrant the denial of this application.

Dated: June 1, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.